Roeen Roashan

Roeen Roashan

Roeen Roashan is an analyst on the Healthcare Technology research team within IHS Technology. His specific areas of coverage include consumer medical and remote monitoring devices and services. Roeen joined IHS as an analyst in April 2013.

Before joining IHS, Roeen held positions in analyst and consulting roles. Roeen received his BSc from Copenhagen Business School in Denmark, where he conducted research on NFC based mobile payment systems.

He received his MBA from California State University Long Beach in Long Beach, CA. Roeen is based in Los Angeles, CA.


Contributions View All (37)

Alexa… Am I healthy?

Technology providers are pushing voice assistants to become a bigger part of consumers’ lives, and given the growing connectivity of things, voice assistants is set to play an operator role to give full control to the user. Up until now, voice assistants have been part of consumer electronics whether it is Amazon’s Alexa, Apple’s Siri, Google Now or Microsoft’s Cortana. These interactive and sometimes intelligent applications are now making their way to healthcare.

Read More
Healthcare Technology
Bose makes hearing aids that aren’t hearing aids

Bose, the audio equipment company, has developed a new device for better hearing called Hearphones – its first product for the digital health market. Hearphones is a personal sound amplification product (PSAP) and is therefore not a regulated medical device, as opposed to devices marketed as hearing aids. From a technical standpoint, the difference is not significant, but where PSAPs mainly serve the purpose of amplification, hearing aids, a $5 billion market, offer treatment for various types of disabling hearing loss including hearing loss across certain frequency ranges, tinnitus, and more.

Read More
Healthcare Technology
Fitbit in trouble – partnering with Medtronic to increase clinical footprint

The last month of calendar year 2016 was busy for Fitbit. The company announced the acquisition of Pebble – an acquisition to enhance its smartwatch products of the future. More interestingly, from a digital health point of view, a partnership with Medtronic was announced. The partnership focuses on integrating data from Fitbit devices in managing diabetes. Diabetics using Medtronic’s iPro myLog mobile app will be able to take in activity and sleep data from Fitbit devices with the purpose of understanding how these metrics affect overall blood glucose levels. Doing this allows for additional precision of managing diabetes in many ways, including providing better care coordination, adjusting drug dosages, and is also an additional avenue of engagement with the patient. So far in 2017, Fitbit has announced the integration of its devices with Qualcomm Life’s 2net platform to enable UnitedHealthcare Motion members using Fitbit activity monitors.

Read More
Healthcare Technology
Share facebook Twitter Google Plus Linked In Add This Contact Us